Medison Co., Ltd. Market Share Analysis of GlobalData now available at ReportsandReports

Dallas, TX: ReportsandReports announce it Medison(2008-2009) 127
Co., Ltd. Market Share Analysis Market Research10 Microbiology Culture In Mexico 129
Report in its Store.10.1 Microbiology Culture, Market Segmentation 129
GlobalData's medical devices report, "Medison Co., Ltd.10.2 Microbiology Culture Market, Mexico, Revenue
Market Share Analysis" provides in-depth informationMix ($m), 2009 130
on Medison's market position in the global ultrasound10.3 Microbiology Culture Market, Mexico, Category
systems market category. The report also providesContribution (%), 2009 131
data and information on the overall competitive10.4 Microbiology Culture Overall Revenue (2002-2016)
landscape in the global ultrasound systems market.132
The report is supplemented with global10.4.1 Microbiology Analyzers Revenue (2002-2016)
corporate-level profile with information on the136
company's business segments, major products and10.5 Microbiology Culture Distribution Share
services, competitors, locations and subsidiaries,(2008-2009) 140
financial deals and other key developments.10.6 Microbiology Culture, Mexico, Company Share
This report is built using data and information sourced(2008-2009) 141
from proprietary databases, primary and secondary11 Overview of Key Companies in Mexico In Vitro
research and in-house analysis by GlobalData's teamDiagnostics Market 142
of industry experts.11.1 F. Hoffmann-La Roche Ltd. 142
Scope11.1.1 Company Overview 142
- Global Company shares (in Revenues) information11.2 Share in the Mexico In Vitro Diagnostics Market
for the in the ultrasound systems market. Other Key142
players covered include Siemens Healthcare, GE11.3 Abbott Laboratories 143
Healthcare, Philips Healthcare, Toshiba Medical11.3.1 Company Overview 143
Systems, ESAOTE, SonoSite, and Hitachi Medical,11.3.2 Share in the Mexico In Vitro Diagnostics Market
among others.143
- Medison's company shares (in Revenues)11.4 Siemens Healthcare 144
information in the global ultrasound systems market.11.4.1 Company Overview 144
- All the key data-points are for 2009 and cover all11.4.2 Share in the Mexico In Vitro Diagnostics Market
the key regions – North America, Europe, Asia144
Pacific (APAC), South Central America (SCA), and11.5 Beckman Coulter, Inc. 145
Middle East and Africa (MEA).11.5.1 Company Overview 145
- Global corporate-level profile with information on the11.5.2 Share in the Mexico In Vitro Diagnostics Market
company's business segments, major products and145
services, competitors, and locations and subsidiaries.11.6 bioMerieux S.A. 146
- Comprehensive coverage of the latest financial11.6.1 Company Overview 146
deals involving the company and its subsidiaries, if any11.6.2 Share in the Mexico In Vitro Diagnostics Market
– Mergers & Acquisitions (M&A), Asset146
Transactions, PE/VC, Equity Offerings, Debt11.7 Ortho-Clinical Diagnostics Inc. 147
Offerings, and Partnerships.11.7.1 Company Overview 147
Reasons to buy11.7.2 Share in the Mexico In Vitro Diagnostics Market
- Develop sales and marketing strategies by147
identifying who-stands-where in the markets, Medison11.8 Inverness Medical Innovations, Inc. 148
operates in.11.8.1 Company Overview 148
- Plan your competition strategies by identifying the11.9 Becton, Dickinson and Company 148
company's shares in the markets and geographic11.9.1 Company Overview 148
regions it operates in.11.10 Bio-Rad Laboratories, Inc. 149
- Design your own inorganic growth and11.10.1 Company Overview 149
business-collaboration strategies by understanding the11.11 Hologic, Inc. 149
financial deals your competitors are involved in.11.11.1 Company Overview 149
- Advance your understanding of the competitive11.12 OLYMPUS CORPORATION 150
landscape and the competitors by leveraging on the11.12.1 Company Overview 150
data and information provided in the report.11.13 Mindray Medical International Limited 150
- Support your overall business strategies by11.13.1 Company Overview 150
leveraging on the key data and information provided11.14 Sysmex Corporation 151
in the report, which includes but not limited to11.14.1 Company Overview 151
Medison's market positions.11.15 Ventana Medical Systems, Inc. 151
1 Table of Contents11.15.1 Company Overview 151
1.1 List of Tables 811.16 DiaSorin S.p.A 151
1.2 List of Figures 1111.16.1 Company Overview 151
2 Introduction 1411.17 Qiagen N.V. 152
2.1 What is This Report About? 1411.17.1 Company Overview 152
3 In Vitro Diagnostics In Mexico 1511.18 Gen-Probe Incorporated 152
3.1 In Vitro Diagnostics, Market Segmentation 1511.18.1 Company Overview 152
3.2 In Vitro Diagnostics, Mexico, Overall Revenue11.19 Phadia AB 152
($m), 2002-2016 1611.19.1 Company Overview 152
3.3 In Vitro Diagnostics Market, Mexico, Revenue Mix12 In Vitro Diagnostics Market Pipeline Products 153
($m), 2009 1812.1 Clinical Chemisty Market Pipeline Products 153
3.4 In Vitro Diagnostics Market, Mexico, Category12.2 Immuno Chemistry Market Pipeline Products 155
Contribution (%), 2009 1912.3 Haematology Market Pipeline Products 156
3.5 In Vitro Diagnostics, Mexico, Company Share12.4 Infectious Immunology Market Pipeline Products
(2008-2009) 25157
4 Clinical Chemistry In Mexico 2612.5 Microbiology Culture Market Pipeline Products 159
4.1 Clinical Chemistry, Market Segmentation 2612.6 Histology and Cytology Market Pipeline Products
4.2 Clinical Chemistry Market, Mexico, Revenue Mix160
($m), 2009 2712.7 Genetic Testing Market Pipeline Products 161
4.3 Clinical Chemistry Market, Mexico, Category13 Financial Deals Landscape 163
Contribution (%), 2009 2813.1 Partnerships 163
4.4 Clinical Chemistry Overall Revenue (2002-2016) 2913.1.1 QIAGEN Enters Into Distribution Agreement
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)With Celera 163
3313.1.2 Sequenom Enters Into Licensing Agreement
4.4.2 Urine Analysis Revenue (2002-2016) 37With Optherion 164
4.5 Clinical Chemistry Distribution Share (2008-2009)13.1.3 QIAGEN Enters Into Licensing Agreement With
41Johns Hopkins University 165
4.6 Clinical Chemistry, Mexico, Company Share13.1.4 OraSure Technologies Enters Into An
(2008-2009) 42Agreement With Roche Diagnostics 166
5 Genetic Testing In Mexico 4413.1.5 Inverness Medical Innovations Enters Into
5.1 Genetic Testing, Market Segmentation 44Distribution Agreement With Epocal 167
5.2 Genetic Testing Market, Mexico, Revenue Mix14 Appendix 168
($m), 2009 4514.1 Definitions of Markets Covered in the Report 169
5.3 Genetic Testing Market, Mexico, Category14.1.1 In Vitro Diagnostics 169
Contribution (%), 2009 4614.2 Research Methodology 176
5.4 Genetic Testing Overall Revenue (2002-2016) 4714.3 Secondary Research 177
5.5 Genetic Testing Distribution Share (2008-2009) 5114.4 Primary Research 177
5.6 Genetic Testing, Mexico, Company Share14.5 Models 178
(2008-2009) 5214.6 Forecasts 178
6 Haematology In Mexico 5414.7 Expert Panels 178
6.1 Haematology, Market Segmentation 5414.8 GlobalData Consulting 178
6.2 Haematology Market, Mexico, Revenue Mix ($m),14.9 Currency Conversion 179
2009 5514.10 Contact Us 179
6.3 Haematology Market, Mexico, Category14.11 Disclaimer 179
Contribution (%), 2009 561.1 List of Tables
6.4 Haematology Overall Revenue (2002-2016) 57Table 1: Medison Co., Ltd., Key Information, 2009 8
6.4.1 Haematology Reagents Revenue (2002-2016) 61Table 2: Diagnostic Imaging, Ultrasound Systems,
6.4.2 Immunohaematology Revenue (2002-2016) 65Global, Company Share by Revenue ($m), 2009 15
6.4.3 Haemostasis Revenue (2002-2016) 69Table 3: Medison Co., Ltd., Diagnostic Imaging,
6.4.4 Haematology Rapid Tests Revenue (2002-2016)Ultrasound Systems, Global, Revenue ($m) and
73Market Share (%), 2009 16
6.4.5 Haematology Cell Counters RevenueTable 4: Medison Co., Ltd., Diagnostic Imaging,
(2002-2016) 75Ultrasound Systems, Asia-Pacific, Revenue ($m) and
6.5 Haematology Distribution Share (2008-2009) 78Market Share (%), 2009 17
6.6 Haematology, Mexico, Company ShareTable 5: Medison Co., Ltd., Diagnostic Imaging,
(2008-2009) 79Ultrasound Systems, Europe, Revenue ($m) and
7 Histology And Cytology In Mexico 81Market Share (%), 2009 18
7.1 Histology and Cytology, Market Segmentation 81Table 6: Medison Co., Ltd., Diagnostic Imaging,
7.2 Histology and Cytology Market, Mexico, RevenueUltrasound Systems, Middle East and Africa, Revenue
Mix ($m), 2009 82($m) and Market Share (%), 2009 19
7.3 Histology and Cytology Market, Mexico, CategoryTable 7: Medison Co., Ltd., Diagnostic Imaging,
Contribution (%), 2009 83Ultrasound Systems, North America, Revenue ($m)
7.4 Histology And Cytology Overall Revenueand Market Share (%), 2009 19
(2002-2016) 84Table 8: Medison Co., Ltd., Diagnostic Imaging,
7.4.1 Histology Revenue (2002-2016) 88Ultrasound Systems, South and Central America,
7.5 Histology and Cytology Distribution ShareRevenue ($m) and Market Share (%), 2009 19
(2008-2009) 92Table 9: Medison Co., Ltd., Key Employees 20
7.6 Histology And Cytology, Mexico, Company ShareTable 10: USD to Local Currency, Average Exchange
(2008-2009) 93Rate 2009 26
8 Immuno Chemistry In Mexico 951.2 List of Figures
8.1 Immuno Chemistry, Market Segmentation 95Figure 1: Diagnostic Imaging, Ultrasound Systems,
8.2 Immuno Chemistry Market, Mexico, Revenue MixGlobal, Company Share (%), 2009 14
($m), 2009 96Figure 2: Medison Co., Ltd., Diagnostic Imaging,
8.3 Immuno Chemistry Market, Mexico, CategoryUltrasound Systems, Global, Market Share (%), 2009
Contribution (%), 2009 9716
8.4 Immuno Chemistry Overall Revenue (2002-2016)Figure 3: Medison Co., Ltd., Diagnostic Imaging,
98Ultrasound Systems, Asia-Pacific, Market Share (%),
8.4.1 Disease Specific Immunochemistry Revenue2009 17
(2002-2016) 102Figure 4: Medison Co., Ltd., Diagnostic Imaging,
8.4.2 Drug Related Testing Revenue (2002-2016) 106Ultrasound Systems, Europe, Market Share (%), 2009
8.4.3 Endocrinology Tests Revenue (2002-2016) 10918
8.4.4 Immunochemistry Analyzers RevenueFigure 5: GlobalData Methodology 23
(2002-2016) 112 
8.5 Immuno Chemistry Distribution Share (2008-2009)About Us:
116Reports and Reports comprises an online library of
8.6 Immuno Chemistry, Mexico, Company Share10,000 reports, in-depth market research studies of
(2008-2009) 117over 5000 micro markets, and 25 industry specific
9 Infectious Immunology In Mexico 119websites. Our client list boasts almost all well-known
9.1 Infectious Immunology, Market Segmentation 119publishers of such reports across the globe. We as a
9.2 Infectious Immunology Market, Mexico, Revenuethird-party reseller of market research reports
Mix ($m), 2009 120employ a number of marketing tools, such as press
9.3 Infectious Immunology Market, Mexico, Categoryreleases, email-marketing and effective search-engine
Contribution (%), 2009 121optimization techniques to drive revenues for our
9.4 Infectious Immunology Overall Revenueclients. We also provide 24/7 online and offline
(2002-2016) 122support service to our customers.
9.5 Infectious Immunology Distribution Share 
(2008-2009) 126Contact:
9.6 Infectious Immunology, Mexico, Company ShareMs.